Insider Buy/Sell Details for the Healthcare Sector — January 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1606)
Ceribell, Inc. (CBLL)
Chao Xingjuan — Director
Shares
1,446
Price
$21.21
Total Value
$30.67K
Shares Held After
741,248
% of Holdings
0.2%
Ceribell, Inc. (CBLL)
Chao Xingjuan — Director
Shares
54,000
Price
$21.31
Total Value
$1.15M
Shares Held After
741,248
% of Holdings
6.8%
Axsome Therapeutics, Inc. (AXSM)
TABUTEAU HERRIOT — Director
Shares
78,703
Price
$171.28
Total Value
$13.48M
Shares Held After
7,229
% of Holdings
91.6%
Ceribell, Inc. (CBLL)
Foehr David — Senior VP, Finance and PAO
Shares
2,153
Price
$22.60
Total Value
$48.66K
Shares Held After
18,900
% of Holdings
10.2%
Ceribell, Inc. (CBLL)
Foehr David — Senior VP, Finance and PAO
Shares
3,403
Price
$22.60
Total Value
$76.91K
Shares Held After
18,900
% of Holdings
15.3%
Movano Inc. (MOVE)
Cogan Jeremy — CFO
Shares
1,879
Price
$8.35
Total Value
$15.69K
Shares Held After
23,325
% of Holdings
7.5%
Acumen Pharmaceuticals, Inc. (ABOS)
Siemers Eric — Chief Medical Officer
Shares
4,000
Price
$1.96
Total Value
$7.83K
Shares Held After
166,298
% of Holdings
2.3%
Acumen Pharmaceuticals, Inc. (ABOS)
OConnell Daniel Joseph — Director
Shares
4,649
Price
$1.97
Total Value
$9.16K
Shares Held After
662,839
% of Holdings
0.7%
Acumen Pharmaceuticals, Inc. (ABOS)
Meisner Derek M — Chief Legal Officer & Corp Sec
Shares
4,000
Price
$1.96
Total Value
$7.84K
Shares Held After
157,127
% of Holdings
2.5%
Acumen Pharmaceuticals, Inc. (ABOS)
Zuga Matt — CFO & Chief Business Officer
Shares
4,000
Price
$1.96
Total Value
$7.84K
Shares Held After
227,744
% of Holdings
1.7%
Acumen Pharmaceuticals, Inc. (ABOS)
Barton Russell — Chief Operating Officer
Shares
4,000
Price
$1.96
Total Value
$7.83K
Shares Held After
132,117
% of Holdings
2.9%
Adaptive Biotechnologies Corp (ADPT)
ROBINS CHAD M — Director
Shares
124,998
Price
$15.59
Total Value
$1.95M
Shares Held After
2,584,243
% of Holdings
4.6%
AN2 Therapeutics, Inc. (ANTX)
Eizen Joshua M — Chief Operating Officer and Chief Legal Officer
Shares
17,923
Price
$1.00
Total Value
$17.95K
Shares Held After
159,430
% of Holdings
10.1%
AN2 Therapeutics, Inc. (ANTX)
Chanda Sanjay — Chief Development Officer
Shares
3,295
Price
$1.00
Total Value
$3.30K
Shares Held After
81,779
% of Holdings
3.9%
AN2 Therapeutics, Inc. (ANTX)
Prior Stephen David — Chief Strategy Officer
Shares
3,604
Price
$1.00
Total Value
$3.61K
Shares Held After
61,944
% of Holdings
5.5%
AN2 Therapeutics, Inc. (ANTX)
Day Lucy — Chief Financial Officer
Shares
3,295
Price
$1.00
Total Value
$3.30K
Shares Held After
80,875
% of Holdings
3.9%
NewAmsterdam Pharma Co N.V. (NAMS)
Kastelein Johannes Jacob Pieter — Director
Shares
6,000
Price
$33.25
Total Value
$199.50K
Shares Held After
73,481
% of Holdings
7.5%
Tempus AI, Inc. (TEM)
Fukushima Ryan — Chief Operating Officer
Shares
5,000
Price
$64.26
Total Value
$321.30K
Shares Held After
148,808
% of Holdings
3.3%
NewAmsterdam Pharma Co N.V. (NAMS)
Kooij Louise Frederika — Chief Accounting Officer
Shares
2,647
Price
$33.25
Total Value
$88.01K
Shares Held After
12,353
% of Holdings
17.6%
NewAmsterdam Pharma Co N.V. (NAMS)
Somaiya Mayur Ian — Chief Financial Officer
Shares
5,118
Price
$33.25
Total Value
$170.17K
Shares Held After
32,882
% of Holdings
13.5%
PharmaCyte Biotech, Inc. (PMCB)
Silverman Joshua — Director
Shares
30,000
Price
$0.78
Total Value
$23.49K
Shares Held After
346,250
% of Holdings
8.7%
Arcutis Biotherapeutics, Inc. (ARQT)
Burnett Patrick — Reporting Person's Title: Executive Vice President and Chief Medical Officer
Shares
2,490
Price
$28.98
Total Value
$72.17K
Shares Held After
94,120
% of Holdings
2.6%
PharmaCyte Biotech, Inc. (PMCB)
SCHECHTER JONATHAN — Director
Shares
20,000
Price
$0.78
Total Value
$15.55K
Shares Held After
152,500
% of Holdings
13.1%
Nuvalent, Inc. (NUVL)
Noci Darlene — Chief Development Officer
Shares
871
Price
$96.06
Total Value
$83.67K
Shares Held After
47,163
% of Holdings
1.8%
Clene Inc. (CLNN)
Ugwumba Chidozie — 10% Owner
Shares
5,869
Price
$5.87
Total Value
$34.45K
Shares Held After
760,611
% of Holdings
0.8%
Nuvalent, Inc. (NUVL)
Porter James Richard — Director
Shares
3,679
Price
$96.06
Total Value
$353.40K
Shares Held After
302,383
% of Holdings
1.2%
Nuvalent, Inc. (NUVL)
Turner Christopher Durant — Chief Medical Officer
Shares
871
Price
$96.06
Total Value
$83.67K
Shares Held After
61,676
% of Holdings
1.4%
Nuvalent, Inc. (NUVL)
Pelish Henry E. — Chief Scientific Officer
Shares
513
Price
$96.06
Total Value
$49.28K
Shares Held After
70,535
% of Holdings
0.7%
Werewolf Therapeutics, Inc. (HOWL)
EVNIN LUKE — Director
Shares
18,378
Price
$0.64
Total Value
$11.76K
Shares Held After
2,453,919
% of Holdings
0.7%
Nuvalent, Inc. (NUVL)
Miller Deborah Ann — Chief Legal Officer
Shares
897
Price
$96.06
Total Value
$86.17K
Shares Held After
48,189
% of Holdings
1.8%
Nuvalent, Inc. (NUVL)
Balcom Alexandra — Chief Financial Officer
Shares
871
Price
$96.06
Total Value
$83.67K
Shares Held After
88,279
% of Holdings
1.0%
Climb Bio, Inc. (CLYM)
RA CAPITAL MANAGEMENT, L.P. — Director
Shares
7,111
Price
$3.50
Total Value
$24.89K
Shares Held After
3,403,429
% of Holdings
0.2%
Intellia Therapeutics, Inc. (NTLA)
BASTA JAMES — EVP, General Counsel
Shares
10,397
Price
$9.21
Total Value
$95.76K
Shares Held After
101,528
% of Holdings
9.3%
Intellia Therapeutics, Inc. (NTLA)
Lebwohl David — EVP, Chief Medical Officer
Shares
11,903
Price
$9.21
Total Value
$109.63K
Shares Held After
121,249
% of Holdings
8.9%
Intellia Therapeutics, Inc. (NTLA)
LEONARD JOHN M — Director
Shares
34,146
Price
$9.21
Total Value
$314.48K
Shares Held After
1,013,339
% of Holdings
3.3%
Travere Therapeutics, Inc. (TVTX)
Inrig Jula — CHIEF MEDICAL OFFICER
Shares
2,031
Price
$40.18
Total Value
$81.61K
Shares Held After
86,756
% of Holdings
2.3%
CASTLE BIOSCIENCES INC (CSTL)
MAETZOLD DEREK J — Director
Shares
2,678
Price
$38.09
Total Value
$102.01K
Shares Held After
30,852
% of Holdings
8.0%
Arcus Biosciences, Inc. (RCUS)
Jaen Juan C. — President
Shares
29,670
Price
$21.34
Total Value
$633.16K
Shares Held After
924,393
% of Holdings
3.1%
Intellia Therapeutics, Inc. (NTLA)
Cohen Fred E — Director
Shares
150,000
Price
$9.35
Total Value
$1.40M
Shares Held After
207,453
% of Holdings
72.3%
Intellia Therapeutics, Inc. (NTLA)
Clark Eliana — EVP, Chief Technical Officer
Shares
9,515
Price
$9.21
Total Value
$87.63K
Shares Held After
87,118
% of Holdings
9.8%
Intellia Therapeutics, Inc. (NTLA)
Dulac Edward J III — EVP, Chief Financial Officer
Shares
6,379
Price
$9.21
Total Value
$58.75K
Shares Held After
99,683
% of Holdings
6.0%
Butterfly Network, Inc. (BFLY)
Ku Victor — Chief Technology Officer
Shares
35,968
Price
$3.82
Total Value
$137.40K
Shares Held After
811,962
% of Holdings
4.2%
Intellia Therapeutics, Inc. (NTLA)
Dube Michael P — VP, Chief Accounting Officer
Shares
2,989
Price
$9.21
Total Value
$27.53K
Shares Held After
52,277
% of Holdings
5.4%
Intellia Therapeutics, Inc. (NTLA)
Schultes Birgit C — EVP, Chief Scientific Officer
Shares
8,508
Price
$9.21
Total Value
$78.36K
Shares Held After
98,533
% of Holdings
7.9%
INCYTE CORP (INCY)
Stein Steven H — EVP & Chief Medical Officer
Shares
15,634
Price
$101.70
Total Value
$1.59M
Shares Held After
34,203
% of Holdings
31.4%
IRONWOOD PHARMACEUTICALS INC (IRWD)
Silver Ronald — Principal Accounting Officer
Shares
35,416
Price
$4.60
Total Value
$162.91K
Shares Held After
276,809
% of Holdings
11.3%
Indivior Pharmaceuticals, Inc. (INDV)
Humphreys Keith — Director
Shares
775
Price
$35.39
Total Value
$27.43K
Shares Held After
5,802
% of Holdings
13.4%
Indivior Pharmaceuticals, Inc. (INDV)
Ryan Barbara — Director
Shares
775
Price
$35.39
Total Value
$27.43K
Shares Held After
1,963
% of Holdings
39.5%
Indivior Pharmaceuticals, Inc. (INDV)
Stejbach Mark — Director
Shares
775
Price
$35.39
Total Value
$27.43K
Shares Held After
16,847
% of Holdings
4.6%
Indivior Pharmaceuticals, Inc. (INDV)
NINIVAGGI DANIEL A — Director
Shares
775
Price
$35.39
Total Value
$27.43K
Shares Held After
16,923
% of Holdings
4.6%
Showing 1401–1450 of 1606 transactions (page 29 of 33)